BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 38608069)

  • 21. A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma.
    Luo L; Li L; Liu L; Feng Z; Zeng Q; Shu X; Cao Y; Li Z
    Front Genet; 2022; 13():833928. PubMed ID: 35330731
    [No Abstract]   [Full Text] [Related]  

  • 22. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer.
    Liu Z; Liu L; Weng S; Guo C; Dang Q; Xu H; Wang L; Lu T; Zhang Y; Sun Z; Han X
    Nat Commun; 2022 Feb; 13(1):816. PubMed ID: 35145098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges.
    Lin A; Yan WH
    Front Immunol; 2021; 12():698677. PubMed ID: 34276691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteasome Subunit Alpha Type 7 Promotes Proliferation and Metastasis of Gastric Cancer Through MAPK Signaling Pathway.
    Xia S; Ji L; Tang L; Zhang L; Zhang X; Tang Q; Feng Z; Lu L
    Dig Dis Sci; 2022 Mar; 67(3):880-891. PubMed ID: 33721161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.
    Dai Y; Qiang W; Lin K; Gui Y; Lan X; Wang D
    Cancer Immunol Immunother; 2021 Apr; 70(4):967-979. PubMed ID: 33089373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TIMER2.0 for analysis of tumor-infiltrating immune cells.
    Li T; Fu J; Zeng Z; Cohen D; Li J; Chen Q; Li B; Liu XS
    Nucleic Acids Res; 2020 Jul; 48(W1):W509-W514. PubMed ID: 32442275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large-scale public data reuse to model immunotherapy response and resistance.
    Fu J; Li K; Zhang W; Wan C; Zhang J; Jiang P; Liu XS
    Genome Med; 2020 Feb; 12(1):21. PubMed ID: 32102694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of PSMA7 predicts poor prognosis in patients with gastric cancer.
    Xia S; Tang Q; Wang X; Zhang L; Jia L; Wu D; Xu P; Zhang X; Tang G; Yang T; Feng Z; Lu L
    Oncol Lett; 2019 Nov; 18(5):5341-5349. PubMed ID: 31612044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer.
    Liu L; Bai X; Wang J; Tang XR; Wu DH; Du SS; Du XJ; Zhang YW; Zhu HB; Fang Y; Guo ZQ; Zeng Q; Guo XJ; Liu Z; Dong ZY
    Clin Cancer Res; 2019 Dec; 25(24):7413-7423. PubMed ID: 31515453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA CircCACTIN Promotes Gastric Cancer Progression by Sponging MiR-331-3p and Regulating TGFBR1 Expression.
    Zhang L; Song X; Chen X; Wang Q; Zheng X; Wu C; Jiang J
    Int J Biol Sci; 2019; 15(5):1091-1103. PubMed ID: 31182928
    [No Abstract]   [Full Text] [Related]  

  • 32. Delivery technologies for cancer immunotherapy.
    Riley RS; June CH; Langer R; Mitchell MJ
    Nat Rev Drug Discov; 2019 Mar; 18(3):175-196. PubMed ID: 30622344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KLK6 Promotes Growth, Migration, and Invasion of Gastric Cancer Cells.
    Zhu S; Shi J; Zhang S; Li Z
    J Gastric Cancer; 2018 Dec; 18(4):356-367. PubMed ID: 30607299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer cell adhesome and degradome interact to drive metastasis.
    Rizwan A; Cheng M; Bhujwalla ZM; Krishnamachary B; Jiang L; Glunde K
    NPJ Breast Cancer; 2015; 1():15017. PubMed ID: 28721370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastric cancer: Metabolic and metabolomics perspectives (Review).
    Xiao S; Zhou L
    Int J Oncol; 2017 Jul; 51(1):5-17. PubMed ID: 28535006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126.
    Wang J; Zhou Y; Fei X; Chen X; Yan J; Liu B; Zhu Z
    Oncol Rep; 2017 Apr; 37(4):2033-2040. PubMed ID: 28260063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade.
    Charoentong P; Finotello F; Angelova M; Mayer C; Efremova M; Rieder D; Hackl H; Trajanoski Z
    Cell Rep; 2017 Jan; 18(1):248-262. PubMed ID: 28052254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Degradome database: expanding roles of mammalian proteases in life and disease.
    Pérez-Silva JG; Español Y; Velasco G; Quesada V
    Nucleic Acids Res; 2016 Jan; 44(D1):D351-5. PubMed ID: 26553809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inferring tumour purity and stromal and immune cell admixture from expression data.
    Yoshihara K; Shahmoradgoli M; Martínez E; Vegesna R; Kim H; Torres-Garcia W; Treviño V; Shen H; Laird PW; Levine DA; Carter SL; Getz G; Stemke-Hale K; Mills GB; Verhaak RG
    Nat Commun; 2013; 4():2612. PubMed ID: 24113773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiological and molecular aspects of degradation of plant polysaccharides by fungi: what have we learned from Aspergillus?
    Culleton H; McKie V; de Vries RP
    Biotechnol J; 2013 Aug; 8(8):884-94. PubMed ID: 23674519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.